"Prazosin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
Descriptor ID |
D011224
|
MeSH Number(s) |
D03.633.100.786.750
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Prazosin".
Below are MeSH descriptors whose meaning is more specific than "Prazosin".
This graph shows the total number of publications written about "Prazosin" by people in this website by year, and whether "Prazosin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 0 | 1 |
1997 | 0 | 1 | 1 |
2003 | 0 | 1 | 1 |
2005 | 0 | 1 | 1 |
2009 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prazosin" by people in Profiles.
-
Pharmacological and non-pharmacological treatments for nightmare disorder. Int Rev Psychiatry. 2014 Apr; 26(2):225-36.
-
?2-adrenergic receptors mediate cardioprotection through crosstalk with mitochondrial cell death pathways. J Mol Cell Cardiol. 2011 Nov; 51(5):781-9.
-
Visible and invisible wounds. J Psychiatr Pract. 2009 Nov; 15(6):429.
-
Comparison of cystometric methods in female rats. Neurourol Urodyn. 2008; 27(4):324-9.
-
Previous exposure to cocaine enhances cocaine self-administration in an alpha 1-adrenergic receptor dependent manner. Neuropsychopharmacology. 2007 Mar; 32(3):638-45.
-
Prazosin, an alpha-1 adrenergic antagonist, reduces cocaine-induced reinstatement of drug-seeking. Biol Psychiatry. 2005 May 15; 57(10):1202-4.
-
High prevalence of orthostatic hypotension and its correlation with potentially causative medications among elderly veterans. J Clin Pharm Ther. 2005 Apr; 30(2):173-8.
-
Evidence favoring the use of an alpha2-selective vasopressor agent for cardiopulmonary resuscitation. Circulation. 2003 Nov 25; 108(21):2716-21.
-
Inhibition of glutamatergic synaptic input to spinal lamina II(o) neurons by presynaptic alpha(2)-adrenergic receptors. J Neurophysiol. 2002 Apr; 87(4):1938-47.
-
Functional characterization of alpha1-adrenergic receptors in experimental vein grafts. J Surg Res. 1999 Jun 01; 84(1):40-5.